Inventor
MICHAEL MAN-CHU LO
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations44%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes13%
C07KPeptides13%
PatentTitleYear
12,178,842PCSK9 antagonist compounds202411,970,4793-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor202411,484,565PCSK9 antagonist compounds202211,339,1563-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor202211,319,298Heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor202211,230,5566,5-fused heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor202211,149,0363-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2022Patents assigned to MERCK SHARP & DOHME (4)· patent assignee history
2021–2024Patents assigned to MSD R&D CHINA CO LTD (4)· patent assignee history
2021Patents assigned to ACTON III JOHN J (1)· patent assignee history
2021Patents assigned to BAO JIANMING (1)· patent assignee history
2021–2024Based in US· patent location history
2022–2024Patents assigned to MERCK SHARP & DOHME LLC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 4 | 2021–2022 |
| MSD R&D CHINA CO LTD | 4 | 2021–2024 |
| MERCK SHARP & DOHME LLC | 3 | 2022–2024 |
| ACTON III JOHN J | 1 | 2021 |
| BAO JIANMING | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2024 |